Seyed Moayed Alavian

Active 2002–2023

62
Papers
28,472
Citations
47
h-index
61
i10-index

Citations

Citations per year for Seyed Moayed Alavian1985: 1 citations2000: 1 citations2003: 2 citations2004: 5 citations2005: 4 citations2006: 10 citations2007: 8 citations2008: 18 citations2009: 7 citations2010: 15 citations2011: 13 citations2012: 14 citations2013: 14 citations2014: 26 citations2015: 34 citations2016: 42 citations2017: 53 citations2018: 131 citations2019: 941 citations2020: 1,879 citations2021: 2,088 citations2022: 1,540 citations2023: 958 citations2024: 1,481 citations2025: 521 citations2026: 20 citations1986–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,579 citing papers, 13.4% of this breakdownChina: 2,572 citing papers, 13.3% of this breakdownUnited Kingdom: 1,461 citing papers, 7.6% of this breakdownAustralia: 919 citing papers, 4.8% of this breakdownCanada: 692 citing papers, 3.6% of this breakdownGermany: 690 citing papers, 3.6% of this breakdownItaly: 596 citing papers, 3.1% of this breakdownSpain: 479 citing papers, 2.5% of this breakdownIran: 442 citing papers, 2.3% of this breakdownNetherlands: 442 citing papers, 2.3% of this breakdownIndia: 422 citing papers, 2.2% of this breakdownSwitzerland: 378 citing papers, 1.9% of this breakdown
0%13.4%Other 39.4%

Fields

  • Medicine59.2%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Neuroscience5.5%
  • Psychology5.3%
  • Environmental Science3.9%
  • Health Professions3.4%
  • Other14.9%

Topics

  • Liver Disease Diagnosis and Treatment2.1%
  • Musculoskeletal pain and rehabilitation2%
  • Nutritional Studies and Diet1.3%
  • Hepatitis C virus research1.2%
  • Tryptophan and brain disorders1.2%
  • Hepatitis B Virus Studies1.1%
  • Other91.1%

Coauthors

All papers

Open in search
  1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Rakesh Aggarwal, Sargis A. Aghayan, Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Nadia Akseer, Ziyad Al‐Aly, Ayman Al‐Eyadhy, Hesham M. Al‐Mekhlafi, Rajaa Al‐Raddadi, Fares Alahdab, Khurshid Alam, Shazia Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh‐Navaei, Syed Mohamed Aljunid, Ala’a Alkerwi, François Alla, Peter Allebeck, Mohamed M L Alouani, Khalid A Altirkawi, Nelson Alvis‐Guzmán, Azmeraw T. Amare, Léopold Ndemnge Aminde, Walid Ammar, Yaw Ampem Amoako, Nahla Anber, Cătălina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Carl Abelardo T. Antonio, Palwasha Anwari, Jalal Arabloo, Antonio Araúz, Olatunde Aremu, Filippo Ariani, Bahroom Armoon, Johan Ärnlöv, Amit Arora, Al Artaman, Krishna K Aryal, Hamid Asayesh, Rana Jawad Asghar, Zerihun Ataro, Sachin Atre, Marcel Ausloos, Leticia Ávila‐Burgos, Euripide Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Peter Azzopardi, Arefeh Babazadeh, Hamid Badali, Alaa Badawi, Ayele Geleto and 890 more - The Lancet 2018 cited by 14,041

  2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zanfina Ademi, Olatunji Adetokunboh, Mina G Adib, Amha Admasie, José Carmelo Adsuar, Kossivi Agbélénko Afanvi, Mohsen Afarideh, Gina Agarwal, Anju Aggarwal, Sargis A. Aghayan, Anurag Agrawal, Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Mohammad Esmaeil Akbari, Tomi Akinyemiju, Nadia Akseer, Ziyad Al‐Aly, Ayman Al‐Eyadhy, Hesham M. Al‐Mekhlafi, Fares Alahdab, Khurshid Alam, Samiah Alam, Shazia Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Komal Ali, Syed Mustafa Ali, Mehran Alijanzadeh, Reza Alizadeh‐Navaei, Syed Mohamed Aljunid, Ala’a Alkerwi, François Alla, Ubai Alsharif, Khalid A Altirkawi, Nelson Alvis‐Guzmán, Azmeraw T. Amare, Walid Ammar, Nahla Anber, Jason A Anderson, Cătălina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Josep M. Antó, Carl Abelardo T. Antonio, Palwasha Anwari, Lambert Appiah, Seth Christopher Yaw Appiah, Jalal Arabloo, Olatunde Aremu, Johan Ärnlöv, Al Artaman, Krishna Kumar Aryal, Hamid Asayesh, Zerihun Ataro, Marcel Ausloos, Euripide Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Ayuk Betrand Tambe, Peter Azzopardi and 943 more - The Lancet 2018 cited by 5,028

  3. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kossivi Agbelenko Afanvi, Mohsen Afarideh, Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Rakesh Aggarwal, Sargis Aghasi Aghayan, Anurag Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Sayem Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Nadia Akseer, Ziyad Al-Aly, Ayman Al-Eyadhy, Hesham M Al-Mekhlafi, Rajaa M Al-Raddadi, Fares Alahdab, Khurshid Alam, Tahiya Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh-Navaei, Syed Mohamed Aljunid, Ala'a Alkerwi, François Alla, Peter Allebeck, Jordi Alonso, Ubai Alsharif, Khalid Altirkawi, Nelson Alvis-Guzman, Leopold N Aminde, Erfan Amini, Mohammadreza Amiresmaili, Walid Ammar, Yaw Ampem Amoako, Nahla Hamed Anber, Catalina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Carl Abelardo T Antonio, Palwasha Anwari, Jalal Arabloo, Olatunde Aremu, Johan Ärnlöv, Amit Arora, Megha Arora, Al Artaman, Krishna K Aryal, Hamid Asayesh, Zerihun Ataro, Marcel Ausloos, Leticia Avila-Burgos, Euripide F G A Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Peter S Azzopardi, Arefeh Babazadeh, Hamid Badali, Kalpana Balakrishnan and 880 more - The Lancet 2018 cited by 4,191

  4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amarsanaa Jazag, Motswedi Anderson, Monique Andersson, Paige Armstrong, Tarik Asselah, Kostas Athanasakis, Oidov Baatarkhuu, Ziv Ben‐Ari, Aïcha Bensalem, Fernando Bessone, Mia Biondi, Abdul Rahman Bizri, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Carol Brosgart, Kimberly Brown, Robert Brown, Jr, Philip Bruggmann, Maurizia Brunetto, Maria Buti, Joaquin Cabezas, Teresa Casanovas, Chungman Chae, Henry Lik Yuen Chan, Hugo Cheinquer, Pei-Jer Chen, Kent Jason Cheng, Myeong-Eun Cheon, Cheng-Hung Chien, Gourdas Choudhuri, Peer Brehm Christensen, Wan-Long Chuang, Vladimir Chulanov, Laura Cisneros, Carla Coffin, Fernando Contreras, Nicola Coppola, Markus Cornberg, Benjamin Cowie, Matthew Cramp, Antonio Craxi, Javier Crespo, Fuqiang Cui, Chris Cunningham, Olav Dalgard, Robert De Knegt, Victor De Ledinghen, Gregory Dore, Sylvia Drazilova, Ann-Sofi Duberg, Steve Egeonu, Mohammed Elbadri, Mohamed El-Kassas, Manal El-Sayed, Chris Estes, Ohad Etzion, Elmobashar Farag, Laurent Ferradini, Paulo Ferreira, Robert Flisiak, Xavier Forns, Sona Frankova, James Fung, Edward Gane, Virginia Garcia, Javier García-Samaniego, Manik Gemilyan, Jordan Genov, Liliana Gheorghe and 169 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 404

  5. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

    Authors: , , , , , , - Nutrition & Metabolism 2019 cited by 204

  6. Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

    Authors: , , , , , , , - Phytotherapy Research 2019 cited by 86

  7. Hepatoprotective effect of quercetin: From chemistry to medicine

    Authors: , , , , , , , , , - Food and Chemical Toxicology 2016 cited by 213

  8. The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial

    Authors: , , , , , - European Journal of Clinical Nutrition 2020 cited by 71

  9. RETRACTED ARTICLE: The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial

    Authors: , , , , , - European Journal of Nutrition 2019 cited by 59

  10. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease

    Authors: , , , , - Hepatitis Monthly 2015 cited by 125

  11. Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies

    Authors: , , , , , , , - Hepatitis Monthly 2014 cited by 65

  12. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial

    Authors: , , , , - Nutrition 2013 cited by 79

  13. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

    Authors: , , , , - Hepatitis Monthly 2016 cited by 104

  14. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

    Authors: , , , , - Hepatitis Monthly 2016 cited by 90

  15. Probiotic as a Novel Treatment Strategy Against Liver Disease

    Authors: , , , , - Hepatitis Monthly 2013 cited by 86

  16. Investigating the impact of eight weeks of aerobic and resistance training on blood lipid profile in elderly with non-alcoholic fatty liver disease: a randomized clinical trial.

    Authors: , , - 2019 cited by 24

  17. The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review

    Authors: , , , , - Expert Review of Clinical Immunology 2023 cited by 21

  18. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

    Authors: , , , , , , , - BMC Complementary and Alternative Medicine 2019 cited by 54

  19. Opioid Drugs in Patients With Liver Disease: A Systematic Review

    Authors: , , , , - Hepatitis Monthly 2016 cited by 117

  20. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV− mothers: a meta-analysis

    Authors: , , , - Archives of Gynecology and Obstetrics 2010 cited by 84

  21. Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD)

    Authors: , , , , - Hepatitis Monthly 2013 cited by 75

  22. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 56

  23. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis

    Authors: , , , , , , - Archives of Virology 2020 cited by 40

  24. The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017

    Authors: , - Clinical Liver Disease 2019 cited by 30